LLOYD ALCERA: Open Payments
NPI 1184854259 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$58,238 in 75 payments from 5 companies in 2025. Trend: 2023 $11,506 · 2024 $21,738 · 2025 $58,238
Speaker / faculty: $51,439Travel & lodging: $4,364Food & beverage: $2,436
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 38 | $33,695 |
| E.R. Squibb & Sons, L.L.C. | 29 | $24,384 |
| Neurocrine BioSciences, Inc. | 4 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Corium, LLC | 1 | $16 |
Products named: REXULTI, COBENFY, ABILIFY MAINTENA, INGREZZA, ABILIFY ASIMTUFII, CAPLYTA, Azstarys.
Industry payments across NJ — which companies pay providers there.
